HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture

Published:2006-06-12 Issue:9 Volume:20 Page:F9-F13
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Brenner Bluma G,Oliveira Maureen,Doualla-Bell Florence,Moisi Daniela D,Ntemgwa Michel,Frankel Fernando,Essex Max,Wainberg Mark A

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference30 articles.

1. The impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance;Spira;J Antimicrob Chemother,2003

2. Regional variations in the African epidemics;Essex,2002

3. Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration;Kantor;PLOS Med,2005

4. WHO–UNAIDS Network for HIV Isolation and Characterization. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000;Osmanov;J Acquir Immune Defic Syndr,2002

5. A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors;Brenner;AIDS,2003

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic and antiretroviral drug resistance mutations analysis of reverse transcriptase and protease gene from Pakistani people living with HIV-1;PLOS ONE;2023-08-24

2. New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates?;FEMS Microbiology Reviews;2022-09-20

3. Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment;Pediatric Infectious Disease Journal;2022-07-20

4. Public availability of HIV-1 drug resistance sequence and treatment data: a systematic review;The Lancet Microbe;2022-05

5. Antiretroviral Drug Treatment of Individuals that Used Preexposure Prophylaxis (PrEP) Before Diagnosis;Current Treatment Options in Infectious Diseases;2021-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3